Digital Dermatoscopy — Mole & Pigmented Lesion Check

Digital dermatoscopy mole examination at CLED uses the microDERM® digital dermatoscope with access to the DANAOS study database neural network analysis — providing up to 50x magnified images, dual-axis measurements, ABCD-E rule scoring and automated risk stratification, plus image archiving for time-comparative monitoring at follow-up visits. The examination is covered at no charge for patients insured with VZP, VoZP, ZPŠ or ČPZP — a meaningful advantage for anyone monitoring multiple moles or returning for regular surveillance.

Dermatoscopy is a non-invasive optical technique that uses polarised or cross-polarised light and magnification to visualise the internal architecture of pigmented skin lesions — structures invisible to the naked eye. A standard dermoscope reveals pigment network patterns, regression structures, vascular patterns, blue-white veils and other dermoscopic criteria that characterise benign versus potentially malignant lesions. Digital dermatoscopy captures and stores these images electronically, indexed to anatomical location, and retrieves them at subsequent visits for direct comparison with baseline images. At CLED the platform is the microDERM® digital dermatoscope, which connects to the DANAOS study database — a neural network trained on a large European dataset of dermoscopically characterised lesions. This network provides automated ABCD-E rule analysis (Asymmetry, Border, Colour, Dermoscopic structures, Evolution) and a risk stratification score. MUDr. Moskalyková reviews the automated assessment in the full clinical context, including lesion history and patient risk profile, before drawing any conclusions. For patients with multiple pigmented lesions, the digital archive enables a structured surveillance protocol: at each visit, all lesions of concern are re-imaged and compared side by side with the previous visit's images. This time-comparison approach can detect even subtle changes in size, colour, border regularity or internal structure that the unaided eye could not quantify over time. Early detection of change is the primary value: a melanoma identified at 1 mm diameter has a five-year survival rate above 95%; the same lesion at 4 mm has a substantially worse prognosis. Digital surveillance enables this early detection by documenting baseline and tracking deviation objectively. The examination is non-invasive and entirely painless: the patient presents any concerning moles and MUDr. Moskalyková photographs each with the dermatoscope, mapping their anatomical positions. The session takes 20–30 minutes depending on the number of lesions. No preparation is required beyond avoiding self-tan on the areas to be examined. Insurance coverage by VZP, VoZP, ZPŠ and ČPZP — four of the Czech Republic's major health insurers — means that routine dermatoscopic surveillance is accessible to the majority of Czech patients at CLED without any out-of-pocket cost, a practical advantage compared to purely private aesthetic clinics where dermatoscopy is typically self-pay. MUDr. Moskalyková also provides ongoing dispensary care for patients with a confirmed diagnosis of skin malignancy who require specialist follow-up.